Literature DB >> 8170573

Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.

V Rajshekhar1.   

Abstract

We treated 11 patients with a persistent (> 3 months), solitary small cysticercus granuloma and seizures with albendazole in a daily dose of 15 mg/kg body weight for 14 days. At repeat CT examinations performed at intervals of 2.5 to 6 weeks after initiation of therapy, the lesions had resolved in two patients and become significantly smaller (less than 50% of their pretreatment size) in two. Albendazole therapy in responders hastened the resolution of the lesions and confirmed the diagnosis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8170573     DOI: 10.1212/wnl.43.6.1238

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  9 in total

1.  Publication concerning an article single CT (ring) lesion in epilepsy patients: a new observation by Garg et al, Indian Journal of Pediatrics, January-February, 1999, Vol. 66, No. 1, pages 155-157.

Authors:  H S Duggal; S H Nizamie
Journal:  Indian J Pediatr       Date:  1999 Nov-Dec       Impact factor: 1.967

Review 2.  Treatment of neurocysticercosis: current status and future research needs.

Authors:  T E Nash; G Singh; A C White; V Rajshekhar; J A Loeb; J V Proaño; O M Takayanagui; A E Gonzalez; J A Butman; C DeGiorgio; O H Del Brutto; A Delgado-Escueta; C A W Evans; R H Gilman; S M Martinez; M T Medina; E J Pretell; J Teale; H H Garcia
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

3.  Single parenchymal brain cysticercus in the acute encephalitic phase: definition of a distinct form of neurocysticercosis with a benign prognosis.

Authors:  O H Del Brutto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

Review 4.  Neurocysticercosis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

Review 5.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

6.  Clinicoradiological and pathological correlations in patients with solitary cysticercus granuloma and epilepsy: focus on presence of the parasite and oedema formation.

Authors:  V Rajshekhar; G Chacko; R P Haran; M J Chandy; S M Chandi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-09       Impact factor: 10.154

Review 7.  Neurocysticercosis: Diagnostic problems & current therapeutic strategies.

Authors:  Vedantam Rajshekhar
Journal:  Indian J Med Res       Date:  2016-09       Impact factor: 2.375

Review 8.  Managing neurocysticercosis: challenges and solutions.

Authors:  Yannick Fogoum Fogang; Abdoul Aziz Savadogo; Massaman Camara; Dènahin Hinnoutondji Toffa; Anna Basse; Adjaratou Djeynabou Sow; Mouhamadou Mansour Ndiaye
Journal:  Int J Gen Med       Date:  2015-10-16

9.  Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.

Authors:  Bing-Cheng Zhao; Hong-Ye Jiang; Wei-Ying Ma; Da-Di Jin; Hao-Miao Li; Hai Lu; Hideaki Nakajima; Tong-Yi Huang; Kai-Yu Sun; Shu-Ling Chen; Ke-Bing Chen
Journal:  PLoS Negl Trop Dis       Date:  2016-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.